Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine

Because of the rapid mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an effective vaccine against SARS-CoV-2 variants is needed to prevent coronavirus disease 2019 (COVID-19). T cells, in addition to neutralizing antibodies, are an important component of naturally acquired...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jane, Jeon, Ju Hyeong, Xu, Jiangsheng, Langston, Laura Katherine, Marasini, Ramesh, Mou, Stephanie, Montoya, Brian, Melo-Silva, Carolina R., Jeon, Hyo Jin, Zhu, Tianyi, Sigal, Luis J., Xu, Renhuan, Zhu, Huabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076570/
https://www.ncbi.nlm.nih.gov/pubmed/37033973
http://dx.doi.org/10.3389/fimmu.2023.1126392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076570/
https://www.ncbi.nlm.nih.gov/pubmed/37033973
http://dx.doi.org/10.3389/fimmu.2023.1126392

Ejemplares similares